# Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

> **NCT00293722** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1308 (actual)

## Conditions studied

- Arthritis, Psoriatic
- Psoriasis
- Skin Diseases, Papulosquamous

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00293722
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 1308 (ACTUAL)
- **Last updated:** 2014-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293722, "Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00293722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*